Literature DB >> 27696565

Cerebral blood flow laterality derived from arterial spin labeling as a biomarker for assessing the disease severity of parkinson's disease.

Koji Yamashita1, Akio Hiwatashi1, Osamu Togao1, Kazufumi Kikuchi1, Hiroo Yamaguchi2, Yuriko Suzuki3, Ryotaro Kamei1, Ryo Yamasaki2, Jun-Ichi Kira2, Hiroshi Honda1.   

Abstract

PURPOSE: To evaluate cerebral blood flow (CBF) laterality derived from arterial spin labeling (ASL) in early-stage Parkinson's disease (PD) patients compared with those with advanced stages.
MATERIALS AND METHODS: Thirty-eight patients with PD (21 patients in early stages, 17 patients in advanced stages) were retrospectively studied. The CBF maps derived from 3T ASL data were co-registered to the corresponding 3DT1WI using SPM 12 software. Caudate nucleus (CN), putamen (PT), globus pallidus (GP), and thalamus (TH) were manually traced on the representative axial slices of 3DT1WI. CBF of the CN, PT, GP, and TH was measured using corresponding pixels on the co-registered CBF maps. A laterality index (LI) was calculated as the ratio of the contralateral CBF to primary affected side CBF. Each LI was compared between early and advanced stages of PD using the Mann-Whitney U-test. The LIs were also compared between each stage of PD.
RESULTS: In the CN, the LIs were significantly higher in early stages (mean LI ± SD, 95% confidence interval = 1.06 ± 0.14, 1.00-1.13) than in advanced stages (0.94 ± 0.14, 0.87-1.01; P < 0.05). We also observed a tendency toward decreased LIs with disease severity (1.10 ± 0.14, 0.99-1.21 for Hoehn and Yahr stage I; 1.04 ± 0.14, 0.92-1.12 for stage II; 0.96 ± 0.11, 0.89-1.10 for stage III; 0.93 ± 0.17, 0.81-1.05 for stage IV).
CONCLUSION: The evaluation of CBF laterality pattern in the CN using ASL may be useful for assessing the disease severity of PD patients. LEVEL OF EVIDENCE: 3 J. MAGN. RESON. IMAGING 2017;45:1821-1826.
© 2016 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  Parkinson's disease; caudate nucleus; diagnostic imaging; functional laterality; regional blood flow

Mesh:

Substances:

Year:  2016        PMID: 27696565     DOI: 10.1002/jmri.25489

Source DB:  PubMed          Journal:  J Magn Reson Imaging        ISSN: 1053-1807            Impact factor:   4.813


  5 in total

1.  The cerebral blood flow deficits in Parkinson's disease with mild cognitive impairment using arterial spin labeling MRI.

Authors:  Dilek Betul Arslan; Hakan Gurvit; Ozan Genc; Ani Kicik; Kardelen Eryurek; Sevim Cengiz; Emel Erdogdu; Zerrin Yildirim; Zeynep Tufekcioglu; Aziz Müfit Uluğ; Basar Bilgic; Hasmet Hanagasi; Erdem Tuzun; Tamer Demiralp; Esin Ozturk-Isik
Journal:  J Neural Transm (Vienna)       Date:  2020-07-06       Impact factor: 3.575

Review 2.  Recent progress in ASL.

Authors:  Luis Hernandez-Garcia; Anish Lahiri; Jonas Schollenberger
Journal:  Neuroimage       Date:  2018-01-03       Impact factor: 6.556

Review 3.  Brain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson's Disease (PD).

Authors:  Paul Tuite
Journal:  Brain Sci       Date:  2017-06-16

4.  Discriminative pattern of reduced cerebral blood flow in Parkinson's disease and Parkinsonism-Plus syndrome: an ASL-MRI study.

Authors:  Lina Cheng; Xiaoyan Wu; Ruomi Guo; Yuzhou Wang; Wensheng Wang; Peng He; Hanbo Lin; Jun Shen
Journal:  BMC Med Imaging       Date:  2020-07-13       Impact factor: 1.930

5.  Motor asymmetry related cerebral perfusion patterns in Parkinson's disease: An arterial spin labeling study.

Authors:  Song'an Shang; Jingtao Wu; Hongying Zhang; Hongri Chen; Zhengye Cao; Yu-Chen Chen; Xindao Yin
Journal:  Hum Brain Mapp       Date:  2020-10-05       Impact factor: 5.399

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.